(CIX: WRAL30)  1,172.74  up arrow+1.94  (0.17 %)  Updated: 11:57 AM EST, Nov 27 2015
(NQ: Apple)  117.98  down arrow-0.05  (-0.04 %)  Updated: 11:57 AM EST, Nov 27 2015
(NY: QUINTILES)  69.57  up arrow+1.06  (1.55 %)  Updated: 11:56 AM EST, Nov 27 2015
(OP: BASF SE)  82.49  down arrow-0.38  (-0.46 %)  Updated: 11:52 AM EST, Nov 27 2015
(NQ: BioCryst)  10.24  up arrow+0.01  (0.1 %)  Updated: 11:56 AM EST, Nov 27 2015
(NQ: BioDelivery)  6.09  up arrow+0.18  (3.05 %)  Updated: 11:56 AM EST, Nov 27 2015
(NQ: CEMP)  32.77  down arrow-0.04  (-0.12 %)  Updated: 11:56 AM EST, Nov 27 2015
(NQ: Cisco)  27.36  up arrow+0.12  (0.44 %)  Updated: 11:57 AM EST, Nov 27 2015
(NQ: Cree)  27.14  up arrow+0.04  (0.15 %)  Updated: 11:56 AM EST, Nov 27 2015
(NQ: DARA)  0.92  up arrow+0.01  (0.99 %)  Updated: 11:15 AM EST, Nov 27 2015
(NY: EMC)  25.44  up arrow+0.02  (0.08 %)  Updated: 11:56 AM EST, Nov 27 2015
(NQ: Extreme Networks)  4.36  up arrow+0.03  (0.69 %)  Updated: 11:55 AM EST, Nov 27 2015
(NQ: Facebook)  105.25  down arrow-0.16  (-0.15 %)  Updated: 11:57 AM EST, Nov 27 2015
(NY: GLAXOSMITHKLINE)  41.03  up arrow+0.33  (0.8 %)  Updated: 11:56 AM EST, Nov 27 2015
(NQ: Alphabet)  750.30  up arrow+2.15  (0.29 %)  Updated: 11:56 AM EST, Nov 27 2015
(NY: IBM)  138.43  up arrow+0.43  (0.31 %)  Updated: 11:57 AM EST, Nov 27 2015
(NY: LH)  122.70  up arrow+0.88  (0.72 %)  Updated: 11:56 AM EST, Nov 27 2015
(OP: Lenovo Group)  20.92  down arrow-1.28  (-5.77 %)  Updated: 11:27 AM EST, Nov 27 2015
(NY: MRK)  54.10  up arrow+0.38  (0.71 %)  Updated: 11:56 AM EST, Nov 27 2015
(NQ: Microsoft)  53.94  up arrow+0.25  (0.46 %)  Updated: 11:57 AM EST, Nov 27 2015
(NQ: NetApp)  30.75  down arrow-0.01  (-0.03 %)  Updated: 11:56 AM EST, Nov 27 2015
(NY: NOVARTIS AG)  86.24  up arrow+0.29  (0.33 %)  Updated: 11:57 AM EST, Nov 27 2015
(OP: Novozymes A/S)  47.69  up arrow+0.37  (0.78 %)  Updated: 11:56 AM EST, Nov 27 2015
(NY: Pfizer)  32.84  down arrow-0.03  (-0.09 %)  Updated: 11:56 AM EST, Nov 27 2015
(NQ: Pozen)  7.30  up arrow+0.23  (3.18 %)  Updated: 11:56 AM EST, Nov 27 2015
(NY: Red Hat)  82.21  down arrow-0.31  (-0.38 %)  Updated: 11:56 AM EST, Nov 27 2015
(NQ: BBRY)  7.82  down arrow-0.09  (-1.14 %)  Updated: 11:57 AM EST, Nov 27 2015
(NQ: Salix)  172.81    (0 %)  Updated: 08:10 PM EDT, Apr 01 2015
(NQ: SQI)  12.89  up arrow+0.12  (0.94 %)  Updated: 11:56 AM EST, Nov 27 2015

Posts tagged “Biotech & Life Science”

Updated 1:47 p.m. Wednesday

New Alexandria Center to change RTP's innovation, physical landscape

New plans for the Alexandria Center for Science, Technology and Agriculture have been released, and they include a world-class life science incubator and an in-house venture fund.

Alexandria Center - RTP Alexandria Center - RTP

Updated 9:43 a.m. Wednesday

Premium Lock Durham startup Neuro+ teaches kids, and you, to improve attention skills

Neuro+, based in Durham, recently launched their technology, designed to help children--and adults--develop attention skills. The technology was designed with children diagnosed with ADHD in mind, yet is applicable and accessible to anyone that seeks to improve their attention skills.

6:30 a.m. Tuesday

Attention, startups: Application window now open for One NC matching funds

Dollar sign      The state-run program provides matching grants of up to $50,000 to North Carolina businesses that have received either federal Small Business Innovation Research (SBIR) or Small Business Technology Transfer (STTR) grant awards.

Updated 6:08 a.m. Tuesday

Validic signs Quintiles as a client, effective immediately

Validic Quintiles becomes the latest client of Validic. The CRO will leverage Validic's platform to enrich the research experience for biopharmaceutical customers, researchers and patients.

Updated 6:07 a.m. Tuesday

GSK inks $100 million deal with Idera Pharmaceuticals

GSK   GSK has struck a development agreement with Idera Pharmaceuticals, Inc., which develops drugs for patients with renal disease. The deal comes with an up-front payment of $2.5 million to Idera, and is worth as much as $100 million.

Updated 11:45 a.m. Monday

Pfizer, with big footprint in NC, Allergan merging in $160B deal

Pfizer   Drug giant Pfizer and Allergan are merging in a deal valued at $160 billion, according to The Wall Street Journal. Pfizer has a number of operations across North Carolina. The deal would create the world's largest pharmaceutical company in sales.

November 20

AAIPharma/CML investing $16 million, adding 37 jobs To Wilmington HQ

Grand opening of AAIPharma's technology center in 2012 in Wilmington. More growth is on the way. AAIPharma Services Corp./Cambridge Major Laboratories, a drug development and manufacturing company, today announce an investment of $15.8 million to expand its laboratories and global headquarters in Wilmington over the next three years, creating at least 37 new jobs by 2018.

November 18

Female libido drug Addyi not selling

Sprout's little pink pill  In its first month on the market, very few prescriptions have been filled for Addyi, the "female Viagra." Today, a women's health advocacy group launched a campaign cautioning against using the drug.

November 16

Syngenta declines $42 billion acquisition bid from ChemChina

Syngenta's new lab in RTP Agrochemical company Syngenta has rejected the most recent takeover bid from ChemChina, one month after declining a deal worth $47 billion from Monsanto.

November 11

IBM brings Watson to Boston Children's Hospital to diagnose rare pediatric diseases

IBM wants Watson to "see" medical images IBM is partnering with the Boston Children's Hospital with the goal of creating a cognitive system that will help clinicians interpret a child's genome sequencing data, compare this with medical literature, and quickly identify anomalies that may be responsible for the unexplained symptoms.

November 10

Premium Lock Three Triangle firms nab funding

Three Triangle area companies have raised money according to recent regulatory filings. They are two biotechnology companies and a Raleigh-based firm that makes a photo enhancement and sharing app. Two are debt financings and one is an equity raise.

Photofy funded. Photofy funded.

November 10

Google Life Sciences teams up with American Heart Association in $50 million partnership

The American Heart Association and Google Life Sciences, a spinout of their parent company, are investing $50 million in a new initiative to address the challenges in preventing and curing coronary heart disease.

November 9

Duke researchers at Durham Innovation District achieve breakthrough in understanding heart disease

A Duke Medicine research team has identified a new molecular pathway involved in heart attacks and death from heart disease. The team operates out of the Durham Innovation District.

Tags: Duke, Genomics
November 9

CED announces keynote speaker for the CED Life Science Conference

Robert J. Lefkowitz, M.D. Entrepreneurial support organization CED announced that Robert J. Lefkowitz, MD will be the keynote speaker for their annual CED Life Science Conference, held this year March 1-2, 2016.

November 4

Chapel Hill's Cardioxyl gets potential $2 billion buyout deal from Bristol-Myers Squibb

Cardioxyl Pharmaceuticals and Bristol-Myers Squibb have signed an agreement under which Bristol-Myers Squibb will acquire Cardioxyl and its assets in potential $2 billion deal.

November 2

MCNC welcomes global leader in 21st century medicine

Dr. Anthony Atala World-renowned surgeon and researcher Dr. Anthony Atala will share his new approaches to health care and the impact new technologies are having in the medical community in November during NCREN Community Day in Winston-Salem.

October 30

NC Biotech Center names Bullock to head economic development

Bill Bullock named VP for economic develoment at NC Biotech Center. The North Carolina Biotechnology Center has named William O. Bullock senior vice president, economic development & statewide operations.

October 30

United Therapeutics earnings soar above analyst estimates

United Therapeutics Silver Spring, MD and Research Triangle Park-based United Therapeutics Corp. reported earnings that soared over analyst estimates for the third quarter of $5.02 a share on revenues of $386.2 million, up 17.1 percent from the same period a year ago. Analysts had estimated earnings at $2.44 a share.

October 29

GSK sales increase, beats estimates, but profits delcine

GSK GlaxoSmithKline, one of the Research Triangle's largest employers, saw increased sales in the third quarter that beat analysts estimates in the thrid quarter despite declining profits. It reported sales of $9.4 billion in the quarter, up 11 percent over the same period last year, but profits declined to $2.6 billion, a 5 percent drop.

Updated October 28

Premium Lock Durham diagnostics firm SenGenix raises $1M in debt offering

Durham-based diagnostics developer SenGenix Inc. has raised just over a million dollars of a $1.5 million debt offering, according to a regulatory filing. The company is developing point-of-care diagnostic tests based on Duke University Medical Center technology.

SenGenix raises $1M in debt offering. SenGenix raises $1M in debt offering.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith